Results 221 to 230 of about 627,285 (279)

A randomized phase 2 trial of socrodeucitinib in moderate‐to‐severe plaque psoriasis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In moderate‐to‐severe plaque psoriasis, socrodeucitinib (6 mg/12 mg) significantly outperformed placebo at week 12: PASI 75 response rates 28.6%/72.1% vs. 7.5%. Meanwhile, socrodeucitinib illustrated a favourable safety and tolerability profile, warranting further study.
Ling Han   +24 more
wiley   +1 more source

Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growth. [PDF]

open access: yesCell
Abdullah KG   +67 more
europepmc   +1 more source

Adaptation to extreme environments: A review of Antarctic fish physiology

open access: yesJournal of Fish Biology, EarlyView.
Abstract Having evolved in the chronically cold and thermally stable waters of the Southern Ocean (SO) for millions of years, Antarctic fish possess a suite of physiological specializations that enable them to survive at temperatures near the freezing point of seawater. Adaptations include the evolution of antifreeze proteins, modifications of membrane
Seungyeon Lee   +8 more
wiley   +1 more source

Recurrent Severe Viral-Induced Rhabdomyolysis Associated With Underlying Genetic Variants in a Young Adult: A Case Report. [PDF]

open access: yesCureus
Stone AM   +13 more
europepmc   +1 more source

Nutritional Strategies for Recovery-Adaptation Coupling After Exercise: From Muscle Damage to Performance Remodeling. [PDF]

open access: yesNutrients
Mănescu DC   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy